Sector revisions Shionogi & Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-05-15 EDT			5-day change	1st Jan Change
3,080.00 ^JPY	+0.13%		-3.05%	+8.41%

05-13	Shionogi Covid Pill Reduced Infection Risk in Late-Stage Study	MT
05-13	Bain-backed Tanabe Pharma targets three new drug launches a year in Japan	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	SHIONOGI & CO., LTD.							12
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							17
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							19
	Average							22
	Weighted average by Cap.							25